Selective depletion of CD4+CD25+Foxp3+ regulatory T cells by low-dose cyclophosphamide is explained by reduced intracellular ATP levels.
about
Oncolytic viruses as therapeutic cancer vaccinesPotential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosisExploiting the Immunomodulatory Properties of Chemotherapeutic Drugs to Improve the Success of Cancer ImmunotherapyT-Cell Therapy: Options for Infectious DiseasesImmunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS SitesThe role of regulatory T cells in cancer immunologyTargeting and utilizing primary tumors as live vaccines: changing strategiesRepression of miR-142 by p300 and MAPK is required for survival signalling via gp130 during adaptive hypertrophyPigmy MicroRNA: surveillance cops in Therapies kingdomPotential utility of the pan-Bcl-2 inhibitor GX15-070 (obatoclax) in cancer immunotherapy.Dissecting the regulatory microenvironment of a large animal model of non-Hodgkin lymphoma: evidence of a negative prognostic impact of FOXP3+ T cells in canine B cell lymphoma.Presence of FOXP3(+)Treg cells is correlated with colorectal cancer progressionEffect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastomaImmunological and clinical effects of vaccines targeting p53-overexpressing malignancies.GARP is regulated by miRNAs and controls latent TGF-β1 production by human regulatory T cells.Human CD4+CD25+ regulatory T cells are sensitive to low dose cyclophosphamide: implications for the immune response.Phase I-II study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell cancer.Five-year disease-free survival among stage II-IV breast cancer patients receiving FAC and AC chemotherapy in phase II clinical trials of Panagen.Adoptive transfer of cytotoxic T lymphocytes targeting two different antigens limits antigen loss and tumor escapeSynergy of topical toll-like receptor 7 agonist with radiation and low-dose cyclophosphamide in a mouse model of cutaneous breast cancerTreatment with cyclophosphamide supported by various dendritic cell-based vaccines induces diversification in CD4⁺ T cell response against MC38 colon carcinomaExpression of CD39 on Activated T Cells Impairs their Survival in Older Individuals.CD4+Foxp3+ regulatory T cells prolong drug-induced disease remission in (NZBxNZW) F1 lupus mice.Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment.Phase II trial of a GM-CSF-producing and CD40L-expressing bystander cell line combined with an allogeneic tumor cell-based vaccine for refractory lung adenocarcinoma.Long-term intravital imaging of the multicolor-coded tumor microenvironment during combination immunotherapy.Definitive activation of endogenous antitumor immunity by repetitive cycles of cyclophosphamide with interspersed Toll-like receptor agonists.Immunogenicity of murine solid tumor models as a defining feature of in vivo behavior and response to immunotherapyLow dosages: new chemotherapeutic weapons on the battlefield of immune-related disease.Contribution of the immune system to the chemotherapeutic response.Melanoma vaccines: developments over the past 10 years.Regulatory T cells in gastrointestinal tumors.Cancer immunotherapy--revisited.T-regulatory cells: key players in tumor immune escape and angiogenesis.ENTPD1/CD39 is a promising therapeutic target in oncology.Targeting Tregs in Malignant Brain Cancer: Overcoming IDO.Immune modulation by chemotherapy or immunotherapy to enhance cancer vaccines.The interplay between the immune system and chemotherapy: emerging methods for optimizing therapy.Immunotherapy of HPV infection-caused genital warts using low dose cyclophosphamide.Metronomics: towards personalized chemotherapy?
P2860
Q21245758-BFF5A476-D5DD-4F5F-9584-B19FFEE94191Q26746099-BC94245E-74AD-49A9-B766-1F72F1A3A8E6Q26779184-9C4A7536-A980-4D6F-8389-2492FA022F9EQ26786661-DA27D4A0-CF51-4262-BA28-76E5D69E58B3Q26798402-0FD7DA31-4EC5-420C-89BA-7AA75E63664BQ27006663-807D8A58-16BE-45D7-AF7C-DBEECE4EF2FFQ27009348-1E510542-6FB5-4346-9E30-61E88FA5A26EQ28571438-279D6D46-7207-488B-B547-B4498E366619Q28818470-55945B35-28D4-4B37-BF58-4DBBA92FA786Q33940448-909CE3A8-CCE7-4A18-916A-531A6B71AF85Q34041661-5A39F5AC-A4BE-410B-A658-05316ACE14BBQ34042234-3AE7B187-5E15-41DB-A50F-3DDCBD2BC548Q34736639-24714273-0E33-491C-83AA-C8DC3731F412Q34898280-EE455D68-C148-42D4-A2BA-30148A5E50C4Q35010258-9A18A6D6-2E67-4D7A-90AD-AB186B65A7AAQ35078064-7605B97F-B8A3-4180-8EEF-ADD577436400Q35834220-A992CA2B-28F8-44C6-A032-8A6E56204AD6Q36107301-8D924424-C317-4C5D-B873-F0CB34061BD0Q36321054-A323F0E8-4475-40A0-9EE2-AE7DC02385FFQ36476394-23E89A46-EB85-4859-A9D0-991B092750E2Q36498103-F7146560-2DA9-4315-8D8E-D805A4F05C9CQ36853115-7BA6B656-C830-477C-84C8-5698D96005B1Q36903043-A083957F-87C6-4BB9-A9DB-AACCCFF2AFD4Q37323038-F58B4629-6A6B-4328-99C6-C33FF6718F9DQ37355213-644B21F8-B35A-4A2E-97A4-4DDCA61DD0CBQ37520816-898F243B-0694-4E39-8E94-513826623D5CQ37536440-ABE7728E-6A1B-42BC-880F-BBA78294AD4DQ37543402-F4365E4B-3C6D-4C2F-8F05-949620BA816EQ37728232-A684A7FC-CB36-4248-BB90-3BA80D42C771Q37832967-CBD38AF5-C263-408D-917F-991833F9A8E1Q37892595-1AFDF248-3EBF-406A-9992-317A6B2361F5Q37903852-3AF61471-A867-44C6-AFA1-BFA4C9AD56CBQ37908998-16039409-477F-4910-9B77-CF02A73C6E6EQ38006901-332146D3-6D6F-48AC-9AA6-63C295DBC47DQ38023121-DB8871DB-382F-403F-B190-0F692C7D3481Q38110540-FBF4342F-E4C4-45B9-8979-42487219638AQ38161367-07487155-5AA5-4F69-B6BC-98ECE3883D87Q38168953-9BE520F3-A3CD-455C-A2F5-CBC8E9E18C74Q38211240-74581B26-24F5-4C01-85F4-4B2DFC302320Q38218923-C1ADCCB4-37E8-4B24-96A8-B6CB4EDA0C39
P2860
Selective depletion of CD4+CD25+Foxp3+ regulatory T cells by low-dose cyclophosphamide is explained by reduced intracellular ATP levels.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Selective depletion of CD4+CD2 ...... uced intracellular ATP levels.
@en
Selective depletion of CD4+CD2 ...... uced intracellular ATP levels.
@nl
type
label
Selective depletion of CD4+CD2 ...... uced intracellular ATP levels.
@en
Selective depletion of CD4+CD2 ...... uced intracellular ATP levels.
@nl
prefLabel
Selective depletion of CD4+CD2 ...... uced intracellular ATP levels.
@en
Selective depletion of CD4+CD2 ...... uced intracellular ATP levels.
@nl
P2093
P1433
P1476
Selective depletion of CD4+CD2 ...... uced intracellular ATP levels.
@en
P2093
P304
P356
10.1158/0008-5472.CAN-10-0283
P407
P577
2010-05-25T00:00:00Z